Stephane Perreault

Years Active: 2017-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Marisa C Kozlowski, Scott J Miller, Stephane Perreault
Atropisomers: Synthesis, Analysis, and Applications. Accounts of chemical research 56 (3) (2023)
Stephane Perreault, Jayaraman Chandrasekhar, Leena Patel
Atropisomerism in Drug Discovery: A Medicinal Chemistry Perspective Inspired by Atropisomeric Class I PI3K Inhibitors. Accounts of chemical research 55 (18) (2022)
Jayaraman Chandrasekhar, Ryan Dick, Joshua Van Veldhuizen, David Koditek, Eve-Irene Lepist, Mary E McGrath, Leena Patel, Gary Phillips, Kassandra Sedillo, John R Somoza, Joseph Therrien, Nicholas A Till, Jennifer Treiberg, Armando G Villaseñor, Yelena Zherebina, Stephane Perreault
Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (PI3K) β Inhibitor. Journal of medicinal chemistry 61 (15) (2018)
Stephane Perreault, Jayaraman Chandrasekhar, Zhi-Hua Cui, Jerry Evarts, Jia Hao, Joshua A Kaplan, Adam Kashishian, Kathleen S Keegan, Thomas Kenney, David Koditek, Latesh Lad, Eve-Irene Lepist, Mary E McGrath, Leena Patel, Bart Phillips, Joseph Therrien, Jennifer Treiberg, Anella Yahiaoui, Gary Phillips
Discovery of a Phosphoinositide 3-Kinase (PI3K) β/δ Inhibitor for the Treatment of Phosphatase and Tensin Homolog (PTEN) Deficient Tumors: Building PI3Kβ Potency in a PI3Kδ-Selective Template by Targeting Nonconserved Asp856. Journal of medicinal chemistry 60 (4) (2017)

Stephane Perreault.css-eqlu8i{font-size:small;padding-left:4px;}